Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 10-2013 | 12-2012 | 10-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -120 | -4 | N/A | 5 | N/A |
| Depreciation Amortization | N/A | 11 | 0 | N/A | N/A |
| Accounts receivable | N/A | -18 | N/A | -7 | N/A |
| Other Working Capital | 120 | -23 | -3 | -3 | N/A |
| Other Operating Activity | 0 | 20 | 0 | 7 | 0 |
| Operating Cash Flow | $N/A | $-15 | $-3 | $2 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -38 | 0 | N/A | N/A |
| Investing Cash Flow | $N/A | $-38 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 32 | N/A | 3 | N/A |
| Debt Repayment | N/A | -10 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 49 | N/A | 8 | N/A |
| Other Financing Activity | 0 | 8 | 11 | 0 | 0 |
| Financing Cash Flow | $N/A | $78 | $11 | $11 | $N/A |
| Beginning Cash Position | N/A | 26 | N/A | 14 | N/A |
| End Cash Position | N/A | 52 | N/A | 26 | N/A |
| Net Cash Flow | $N/A | $26 | $8 | $13 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -15 | -3 | 2 | N/A |
| Capital Expenditure | N/A | -49 | N/A | N/A | N/A |
| Free Cash Flow | 0 | -64 | -3 | 2 | 0 |